Mark Rubash - Intuitive Surgical Independent Director

ISRG Stock  USD 399.09  1.01  0.25%   

Director

Mr. Mark J. Rubash is Independent Director of the Company. Mr. Rubash is the Chief Financial Officer Emeritus Strategic Advisor at Eventbrite, Inc., a privatelyheld ecommerce company. He was the Chief Financial Officer at Eventbrite from June 2013 to November 2016. Prior to Eventbrite, Mr. Rubash was Chief Financial Officer at Heartflow, Inc., a privatelyheld medical diagnostic services company, which he joined in March 2012. Prior to Heartflow, Mr. Rubash was the Chief Financial Officer at Shutterfly, Inc., an Internetbased social expression and personal publishing company. Prior to joining Shutterfly in November 2007, Mr. Rubash was the Chief Financial Officer of Deem, Inc., an eCommerce platform company, from August 2007 to November 2007 and previous to that, Mr. Rubash was a Senior Vice President at Yahoo Inc. from February 2007 to August 2007. Prior to joining Yahoo, Mr. Rubash held various senior positions at eBay Inc. from February 2001 to July 2005. Prior to that, Mr. Rubash was also an audit partner at PwC, where he was most recently the Global Leader for their Internet Industry Practice and Practice Leader for their Silicon Valley Software Industry Practice. Mr. Rubash received his B.S. in Accounting from California State University Sacramento since 2007.
Age 61
Tenure 17 years
Address 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304
Phone408 523 2100
Webhttps://www.intuitive.com
Rubash has served as a member of the Board of Directors and Chairman of the Audit Committee of Line 6 Corporationration from April 2007 to January 2014 and has served as a member of the Board of Directors of IronPlanet, Inc. from March 2010 to May 2017 and iRhythm Technologies, Inc. since March 2016.

Intuitive Surgical Management Efficiency

The company has return on total asset (ROA) of 0.0777 % which means that it generated a profit of $0.0777 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1483 %, meaning that it created $0.1483 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The Intuitive Surgical's current Return On Capital Employed is estimated to increase to 0.13. The Intuitive Surgical's current Return On Assets is estimated to increase to 0.12. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 8.3 B, while Other Assets are projected to decrease to roughly 1.1 B.
The company currently holds 89.8 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Intuitive Surgical has a current ratio of 5.0, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Intuitive Surgical until it has trouble settling it off, either with new capital or with free cash flow. So, Intuitive Surgical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intuitive Surgical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intuitive to invest in growth at high rates of return. When we think about Intuitive Surgical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Oliver SpandowNephros
N/A
Howard PalefksyEkso Bionics Holdings
N/A
Dan BorenEkso Bionics Holdings
40
Jack PeurachEkso Bionics Holdings
48
Theodore WangEkso Bionics Holdings
51
Charles LiEkso Bionics Holdings
N/A
Malcom PersenNephros
60
Thomas SchreckEkso Bionics Holdings
60
Alisa LaskNephros
N/A
Andrew HuntWarby Parker
N/A
Marilyn HamiltonEkso Bionics Holdings
64
Paul MieyalNephros
45
Thomas GwydirNephros
N/A
Moshe PintoNephros
N/A
Matthew RosenbergNephros
33
Stanley SternEkso Bionics Holdings
60
Ann CooksonEkso Bionics Holdings
N/A
Amy WendellEkso Bionics Holdings
56
Alfred VargasNephros
N/A
Ted WangEkso Bionics Holdings
50
Arthur AmronNephros
61
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. Intuitive Surg operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 9793 people. Intuitive Surgical (ISRG) is traded on NASDAQ Exchange in USA. It is located in 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 and employs 13,676 people. Intuitive Surgical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Intuitive Surgical Leadership Team

Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Rosa, Chief Commercial Officer and Executive VP
Mark Brosius, Senior Officer
Mark Rubash, Independent Director
Michael Friedman, Director
Gary Loeb, G Officer
Robert DeSantis, Executive Officer
Philip Kim, Head Relations
Keith Leonard, Director
Ian Purdy, Senior Assurance
Julian Nikolchev, Sr Strategy
Gillian EdD, Senior ServicesWorldwide
Jamie Samath, Principal Accounting Officer, VP and Corporate Controller
Gary JD, General VP
Amal Johnson, Independent Director
Craig Barratt, Independent Director
Eric Halvorson, Independent Director
Lonnie Smith, Chairman and Executive Officer
Jami Nachtsheim, Independent Director
Gary Guthart, CEO and President and Director
Marc Bland, GM VP
Alan Levy, Independent Director
Don Kania, Director
Myriam Curet, Senior Vice President Chief Medical Officer
Mark Meltzer, Chief Compliance Officer, Sr. VP and General Counsel
Colin Morales, Senior Vice President - Manufacturing and Service Operations
MD FACS, Executive Officer
Glenn Vavoso, Senior APAC
Salvatore Brogna, Executive VP of Product Operations
Brian Miller, Executive Officer
George Stalk, Independent Director
Amy Ladd, Director
Henry Charlton, Senior Officer
Fredrik Widman, Principal VP
Marshall Mohr, Executive Services
Christopher Carlson, Corporate Research

Intuitive Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Intuitive Stock analysis

When running Intuitive Surgical's price analysis, check to measure Intuitive Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intuitive Surgical is operating at the current time. Most of Intuitive Surgical's value examination focuses on studying past and present price action to predict the probability of Intuitive Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intuitive Surgical's price. Additionally, you may evaluate how the addition of Intuitive Surgical to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Intuitive Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.857
Earnings Share
5.04
Revenue Per Share
20.285
Quarterly Revenue Growth
0.165
Return On Assets
0.0777
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.